|
|
||||||||
RESEARCH REPORT |
Orthodontic Science, Department of Orofacial Development and Function, Division of Oral Health Sciences, Graduate School, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8549, Japan;
* corresponding author, watarai.orts{at}tmd.ac.jp
| ABSTRACT |
|---|
|
|
|---|
KEY WORDS: nitric oxide occlusal recovery periodontal ligament blood vessel
| INTRODUCTION |
|---|
|
|
|---|
The function and integrity of blood vessels are regulated by the nervous system and several local factors, one of which is nitric oxide (NO). Since NO was discovered as an endothelial-derived relaxing factor in 1987, it has been recognized as a biologically active molecule that has various functions (Moncada et al., 1991). It is synthesized from L-arginine in a process catalyzed by nitric oxide synthase (NOS) (Marletta et al., 1998; Stuehr, 1999). There are many kinds of cells that produce NOS and are classified into three types: endothelial NOS (eNOS), neuronal NOS (nNOS), and inducible NOS (iNOS). Their production appears to be tissue-specific. Endothelial NOS is produced in endothelial cells and osteoclasts (Rubin et al., 2003), and iNOS is produced in vascular smooth-muscle cells, fibroblasts, and macrophages (Sasu et al., 2001; Connelly et al., 2003). The expression of NOS in the PDL and dental pulp of rats, cats, and dogs has been reported (Kerezoudis et al., 1993; Lohinai et al., 1997). These findings suggest the existence of NO in physiologically normal dental pulp and periodontal tissues, and a possible regulatory role in these tissues.
Recent studies have focused on the relationship between mechanical stimuli and NO (Nakago-Matsuo et al., 2000). NO production increased in response to cyclic tension force application in vitro (Kikuiri et al., 2000), whereas administration of NO inhibitor reduced experimental tooth movement in vivo (Hayashi et al., 2002; Shirazi et al., 2002). Few studies are available on the recovery process of atrophic PDL with NO. The objective of this study was to examine the changes in the PDL structure and the association of eNOS and iNOS using hypofunction/recovery models.
| MATERIALS & METHODS |
|---|
|
|
|---|
|
|
We confirmed the specificity of immunostaining by omitting anti-mouse IgG or ABC complex, or by replacing primary antibody with PBS. Immunostaining was not observed in sections of the negative control. Sections of lung tissue from the normal rats were used as a positive control (Monica et al., 2002).
Quantitative Analysis
The cross-sections at the level of 500600 µm from the furcation of the disto-palatal roots of the maxillary first molars were chosen for quantitative analysis. The blood vessel diameter, the number of NOS-immunopositive cells, and the total NOS-immunopositive area were measured in a square area of interest (200 µm x 200 µm, Fig. 2
). We drew the mesiodistal line that passed through the central point of root (which is line
). We determined point P that was the intersection of the line
and the borderline between the distal PDL and alveolar bone. We drew the line that passed through point P and perpendicular to the line
(which is line ß). We made a square as Fig. 2
.
The immunostained specimens were observed and photographed by a light microscope (Nikon Microphoto-FXA, Nikon, Tokyo, Japan) equipped with a digital camera (DXm1200, Nikon, Tokyo, Japan), and stored in a 24-bit true-color TIFF format. Measurement was performed 3 times in the representative section obtained from the 12 samples of each group by means of image analysis software (Image-Pro, Media Cybernetics, Silver Spring, MD, USA) (ODonnell et al., 1995; Hoang et al., 1997). The blood vessel diameter was measured by a scale provided by the software. The number of NOS-immunopositive cells was counted manually. Analogue microscopic images were converted into digital images, and the image analysis program was used to establish a threshold and measure the immunopositive area. A threshold that defined the cell margin was established with the software, and the total immunostained area in the digital images measured. Twelve rats in each group were used to measure NOS-immunopositive cells and the summary of the NOS-immunopositive area. Each section was counted on 3 different days, and 5 consecutive sections per animal were counted to correct differences in observation. The size of a cell was estimated as NOS-immunopositive area/NOS-immunopositive cell number in each group, and the cell sizes of the 3 groups compared. The number of NOS-immunopositive cells and the total immunopositive area were analyzed by ANOVA followed by Scheffés post hoc test (p < 0.05), with the use of Statview 5.0J software (SAS Institute, Cary, NC, USA).
| RESULTS |
|---|
|
|
|---|
The normal and occlusal hypofunction groups had identifiable eNOS only in blood vessels (Figs. 3A
, 3B
). In the occlusal recovery group, eNOS was detected in blood vessels, and in mononuclear phagocyte lineage at the border of the PDL and alveolar bone (Fig. 3C
). After 7 days of induced hypofunction, the number of eNOS-immunopositive cells and the eNOS-immunopositive area were significantly decreased (p < 0.05) when compared with that of the normal group. In contrast, following 7 days of occlusal recovery, there were significant (p < 0.05) increases in the number of eNOS-immunopositive cells (1.58 times) and the eNOS-immunopositive area (2.13 times). These levels were not significantly different from those found in control conditions (Figs. 4A
, 4C
).
|
|
During the hypofunctional period, the cell size was 0.75 times in eNOS-immunopositive cells and 0.79 times in iNOS-immunopositive cells compared with that of the controls. In contrast, during the recovery period, the cell size was 1.35 times in eNOS-immunopositive cells and 1.30 times in iNOS-immunopositive cells compared with that of the hypofunctional groups. The difference in cell size between the control and the occlusal recovery groups was not significant.
| DISCUSSION |
|---|
|
|
|---|
Our observation of inducible NOS in blood vessels, mononuclear phagocyte lineage, and fibroblasts has not been reported previously for PDL, but has been reported in other organs (Warner et al., 1995). Following 7 days of hypofunction, iNOS-immunoreactivity significantly decreased in comparison with normal control. It returned to near-control levels after recovery. NO production has been shown to be associated to frequency of stimuli and degree of stretching force (Kikuiri et al., 2000). Although the effect of compression is unknown, these results suggest that PDL cells may produce NO by many types of mechanical stress. Although inducible NOS was not affected by shear stress in a previous study (Wagner et al., 1997), a second study had demonstrated that cyclic tension force enhanced the production of interleukin-1-beta (IL-1ß) (Shirazi et al., 2002). IL-1 is a chemical mediator that is known to promote synthesis of iNOS in vascular smooth-muscle cells. Therefore, the increase in iNOS level may be the indirect effect of IL-1 activation as a result of altered occlusal stimuli (Shirazi et al., 2002).
The change in the NOS-immunopositive area was greater than the NOS-immunopositive cell number in both eNOS and iNOS. These findings indicate that the cell size as well as the cell number decreased in hypofunction and increased nearly to control in the recovery period. The change in iNOS expression in the occlusal recovery period was greater than that of eNOS. After activation of cells by different inducers (bacterial, cytokines), iNOS is expressed and active for hours to days as a "high-output" enzyme (MacMicking et al., 1997). The result of our study, in terms of change in iNOS, is consistent with this study.
In summary, this study demonstrated that the production of eNOS and iNOS decreased in hypofunctional PDL and increased following occlusal function recovery. If an increase in NO is assumed to accompany the increase in eNOS and iNOS in occlusal recovery, NO in PDL may be partially regulated by occlusal stimuli. This mediator may play an important regulatory role for blood vessel expansion and as a mediator of mechanical stress, maintaining the integrity of periodontal tissues under physiological conditions.
| ACKNOWLEDGMENTS |
|---|
Received February 24, 2003; Last revision February 2, 2004; Accepted February 3, 2004
| REFERENCES |
|---|
|
|
|---|
Connelly L, Jacobs AT, Palacios-Callender M, Moncada S, Hobbs AJ (2003). Macrophage endothelial nitric-oxide synthase autoregulates cellular activation and pro-inflammatory protein expression. J Biol Chem 278:2648026487.
Ermert M, Ruppert C, Gunther A, Duncker HR, Seeger W, Ermert L (2002). Cell-specific nitric oxide synthase-isoenzyme expression and regulation in response to endotoxin in intact rat lungs. Lab Invest 82:425441.[ISI][Medline]
Hayashi K, Igarashi K, Miyoshi K, Shinoda H, Mitani H (2002). Involvement of nitric oxide in orthodontic tooth movement in rat. Am J Orthod Dentofacial Orthop 122:306309.[ISI][Medline]
Hayashi Y, Iida J, Warita H, Soma K (2001). Effect of occlusal hypofunction on the microvasculature and endothelin expression in the periodontal ligament of rat molar. Orthodontic Waves 60:373380.
Heeringa P, Bijl M, de Jager-Krikken A, Zandvoort A, Dijkstra G, Moshage H, et al. (2001). Renal expression of endothelial and inducible nitric oxide synthase, and formation of peroxynitrate-modified proteins and reactive oxygen species in Wegeners granulomatosis. J Pathol 193:224232.[ISI][Medline]
Hoang AM, Chen D, Oates TW, Jiang C, Harris SE, Cochran DL (1997). Development and characterization of a transformed human periodontal ligament cell line. J Periodontol 68:10541062.[ISI][Medline]
Kaneko S, Ohashi K, Soma K, Yanagishita M (2001). Occlusal hypofunction causes changes of proteoglycan content in the rat periodontal ligament. J Periodontal Res 36:917.[ISI][Medline]
Kerezoudis NP, Olgart L, Fried K (1993). Localization of NADPH-diaphorase activity in the dental pulp, periodontium and alveolar bone of the rat. Histochemistry 100:319322.[ISI][Medline]
Kikuiri T, Hasegawa T, Yoshimura Y, Shirakawa T, Oguchi H (2000). Cyclic tension force activates nitric oxide production in cultured human periodontal ligament cells. J Periodontol 71:533539.[ISI][Medline]
Koike K (1996). The effects of loss and restoration of occlusal function on the periodontal tissues of rat molar teethhistopathological and histometrical investigation. J Jpn Soc Periodontol 38:119.
Lohinai Z, Szekely AD, Benedek P, Csillag A (1997). Nitric oxide synthase containing nerves in the cat and dog dental pulp and gingiva. Neurosci Lett 227:9194.[ISI][Medline]
MacMicking J, Xie QW, Nathan C (1997). Nitric oxide and macrophage function. Annu Rev Immunol 15:323350.[ISI][Medline]
Marletta MA, Hurshman AR, Rusche KM (1998). Catalysis by nitric oxide synthase. Curr Opin Chem Biol 2:656663.[ISI][Medline]
Moncada S, Palmer RM, Higgs EA (1991). Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109142.[ISI][Medline]
Nakago-Matsuo C, Matsuo T, Nakago T (2000). Basal nitric oxide is enhanced by hydraulic pressure in cultured human periodontal ligament fibroblasts. Am J Orthod Dentfac Orthop 117:474478.
ODonnell LR, Alder SL, Balis UJ, Perkins SL, Kjeldsberg CR (1995). Immunohistochemical reference ranges for B lymphocytes in bone marrow biopsy paraffin sections. Am J Clin Pathol 104:517523.[ISI][Medline]
Rubin J, Murphy TC, Zhu L, Roy E, Nanes MS, Fan X (2003). Mechanical strain differentially regulates endothelial nitric-oxide synthase and receptor activator of nuclear kappa B ligand expression via ERK1/2 MAPK. J Biol Chem 278:3401834025.
Saeki M (1959). Experimental disuse atrophy and its repairing process in the periodontal membrane. J Stomatol Soc Jpn 26:317347.
Sasu S, Cooper AL, Beasley D (2001). Juxtacrine effects of IL-1 alpha precursor promote iNOS expression in vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 280:H1615H1623.
Shirazi M, Nilforoushan D, Alghasi H, Dehpour AR (2002). The role of nitric oxide in orthodontic tooth movement in rats. Angle Orthod 72:211215.[ISI][Medline]
Stuehr DJ (1999). Mammalian nitric oxide synthase. Biochim Biophys Acta 1411:217230.[Medline]
Suhr ES, Warita H, Iida J, Soma K (2002). The effect of occlusal hypofunction and its recovery on the periodontal tissues of the rat molar: ED1 immunohistochemical study. Orthodontic Waves 61:165172.
Tanaka A, Iida J, Soma K (1998). Effect of hypofunction on the microvasculature in the periodontal ligament of the rat molar. Orthodontic Waves 57:180188.
Wagner CT, Durante W, Christodoulides N, Hellums JD, Schafer AI (1997). Hemodynamic forces induce the expression of heme oxygenase in cultured vascular smooth muscle cells. J Clin Invest 100:589596.[ISI][Medline]
Warner RL, Paine R 3rd, Christensen PJ, Marletta MA, Richards MK, Willcoxen SE, et al. (1995). Lung sources and cytokine requirements for in vivo expression of inducible nitric oxide synthase. Am J Respir Cell Mol Biol 12:649661.[Abstract]
Watarai H, Warita H, Suhr ES, Soma K (2001). Expression of nitric oxide synthase in rat periodontium under occlusal hypofunction and recovery (abstract). Orthodontic Waves: 305.
Wedgwood S, Bekker JM, Black SM (2001). Shear stress regulation of endothelial NOS in fetal pulmonary arterial endothelial cells involves PKC. Am J Physiol Lung Cell Mol Physiol 281:L490L498.
This article has been cited by other articles:
![]() |
R. Kunii, M. Yamaguchi, Y. Aoki, A. Watanabe, and K. Kasai Effects of experimental occlusal hypofunction, and its recovery, on mandibular bone mineral density in rats Eur J Orthod, February 1, 2008; 30(1): 52 - 56. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Shimomoto, C.J. Chung, Y. Iwasaki-Hayashi, T. Muramoto, and K. Soma Effects of Occlusal Stimuli on Alveolar/Jaw Bone Formation J. Dent. Res., January 1, 2007; 86(1): 47 - 51. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| IADR Journals | Advances in Dental Research ® |
| Journal of Dental Research ® | Critical Reviews (1990-2004) |